News Contact Us

Beverage brand Coolberg raises $3.5 million in Series A funding round

Author : Saipriya Iyer | Published Date : 2019-11-15 

Rising demand for functional brews for the health conscious who do not want to compromise on the taste is pushing the non-alcoholic beverage industry across the world. This globally growing accessibility of non-alcoholic beverages is also driving product popularity among customers, leading to growth in consumption.

Non-alcoholic beverage companies are increasingly working towards new innovations and expansion of product reach. In fact, Coolberg, a Mumbai based non-alcoholic beer startup, reportedly announced that it gathered $3.5 million in a Series A investment round. The round was led by Singapore-based boutique venture fund RB Investments and the company’s existing investor India Quotient.

The investment round also witnessed participation of Ashish Goenka, Chairman at Suashish Diamonds Ltd. and several investors from the Indian Angel Network.

Founder of Coolberg Beverages, Pankaj Aswani stated that the company’s primary objective is to establish a supply chain where wherever customers can find cola, they can also find Coolberg beverages.

Aswani further added that raising this capital would help the company to further strengthen its distribution network and boost brand awareness.

Coolberg already boasts of a strong distribution network. The company products are currently available in approximately 12,000 outlets across India including the country’s major cities. Today, Coolberg beverages are not only available across several restaurants, and supermarkets but are also found in colleges, offices, and airports.  

COO and Co-founder of Coolberg, Yashika Keswani stated that Indian beverage industry is experiencing an interesting shift where there is a growing demand for new flavors. The variants of company are refreshing, unique and new in the country’s beverage market. Keswani further added that the company’s R&D team is powerful and closely monitors consumer demands.  

One of the partners at India Quotient, Madhukar Sinha stated that IQ is thrilled to lead the Series A funding round at Coolberg. The company is impressed with the company’s revenue growth as well as the growing popularity of the brand across the served cities.

Coolberg was innovated by Yashika Keswani and Pankaj Aswani to offer new products to enjoy at hangouts, celebrations, casual meetings, etc. The non-alcoholic beverage brand had previously raised an undisclosed amount in a seed investment round in 2018. Venture capital company India Quotient and IAN (Indian Angel Network) were the initial investors of the company.



Source credit: https://economictimes.indiatimes.com/small-biz/startups/newsbuzz/coolberg-raises-3-5-million-in-series-a-round/articleshow/72037728.cms

About Author

Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i

Related News

Broco Tactical to unveil 3 new products at 2020 SHOT Show in Las Vegas

Published Date: 2020-01-21         Author: Saipriya Iyer

Broco Tactical is reportedly introducing the latest line of forced entry and rescue & repair products in Las Vegas, Nevada, for military, law enforcement, and first responders at 2020 SHOT Show, from 21st-24th January. The California-based company is a part of the Broco Rankin family of companie... Read More

Zymeworks partners with Ibrance and initiates Phase 2 trial

Published Date: 2020-01-14         Author: Saipriya Iyer

Zymeworks Inc., a Vancouver based clinical stage biopharmaceutical company that develops multifunctional therapeutics, has reportedly announced the commencement of Phase 2 trial that assesses ZW25 combination therapy. The company also announced that it has reached consensus on an agreement with Pfiz... Read More

Hikma and Arecor ink new deal to develop and market new medicines

Published Date: 2020-01-11         Author: Saipriya Iyer

Hikma Pharmaceuticals, a renowned UK based biopharmaceutical company, and Arecor, a biopharmaceutical firm advancing today’s treatments to enable healthier lives, have reportedly signed a new strategic agreement to develop a novel injectable medicine in the U.S. from Hikma’s subsidiary, ... Read More

© 2020 Fractovia. All Rights Reserved